{"product_id":"hsic-marketing-mix","title":"Henry Schein, Inc. (HSIC): Marketing Mix Analysis [June-2026 Updated]","description":"\u003cp\u003eThis ready-made Marketing Mix Analysis gives you a practical, research-based view of Henry Schein, Inc. as of late 2025, showing how the company reaches healthcare buyers through \u003cstrong\u003e300,000+\u003c\/strong\u003e branded and private-label products, distribution in \u003cstrong\u003e34\u003c\/strong\u003e countries and territories, service to \u003cstrong\u003e1M+\u003c\/strong\u003e customers, and about \u003cstrong\u003e30,000\u003c\/strong\u003e cartons shipped daily. You’ll also see how its promotion, pricing, and market position are shaped by the \u003cstrong\u003e2025–2027 BOLD+1\u003c\/strong\u003e plan, quarterly guidance, Henry Schein One and Dentrix Ascend announcements, ethical-company recognition, a \u003cstrong\u003e$78.05\u003c\/strong\u003e share price, a \u003cstrong\u003e$61.95–$89.29\u003c\/strong\u003e range, and share repurchases at \u003cstrong\u003e$70.47\u003c\/strong\u003e and \u003cstrong\u003e$77.64\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHenry Schein, Inc. - Marketing Mix: Product\u003c\/h2\u003e\n\n\u003cp\u003eHenry Schein’s product mix is built around \u003cstrong\u003e300,000+\u003c\/strong\u003e branded and private-brand items, plus software and service offerings that support dental and medical workflows.\u003c\/p\u003e\n\n\u003cp\u003eIts core product offering is not a single item. It is a combined portfolio of consumables, equipment, specialty products, software, and homecare supplies that supports purchasing, practice operations, and patient care.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eProduct area\u003c\/th\u003e\n    \u003cth\u003eWhat it includes\u003c\/th\u003e\n    \u003cth\u003eWhy it matters\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eBranded and private-brand items\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e300,000+\u003c\/strong\u003e products\u003c\/td\u003e\n    \u003ctd\u003eGives customers one source for high-frequency purchases and differentiated value items\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDental distribution\u003c\/td\u003e\n    \u003ctd\u003eConsumables, equipment, implants, and practice supplies\u003c\/td\u003e\n    \u003ctd\u003eSupports recurring demand from dental practices and clinics\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eMedical distribution\u003c\/td\u003e\n    \u003ctd\u003eSupplies, equipment, and practice-related products for medical customers\u003c\/td\u003e\n    \u003ctd\u003eExpands the customer base beyond dentistry\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSpecialty dental products\u003c\/td\u003e\n    \u003ctd\u003eImplants and endodontics\u003c\/td\u003e\n    \u003ctd\u003eRaises average selling price and supports higher-value clinical workflows\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSoftware\u003c\/td\u003e\n    \u003ctd\u003eHenry Schein One software and Dentrix Ascend\u003c\/td\u003e\n    \u003ctd\u003eMoves the product mix into recurring digital revenue and workflow control\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHomecare supplies\u003c\/td\u003e\n    \u003ctd\u003eAcentus continuous glucose monitoring supplies\u003c\/td\u003e\n    \u003ctd\u003eAdds a patient-facing supply category with recurring usage\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe \u003cstrong\u003e300,000+\u003c\/strong\u003e item assortment matters because it lets Henry Schein serve routine ordering and specialty purchasing through the same relationship. For customers, that reduces the number of vendors they need to manage. For Henry Schein, it increases the chance of cross-selling across consumables, equipment, and software.\u003c\/p\u003e\n\n\u003cp\u003eIn dental distribution, the product mix typically covers the items practices buy repeatedly, such as gloves, masks, disinfectants, cements, anesthetics, restorative materials, and clinical equipment. This category is important because it creates repeat demand and helps anchor customer relationships around daily operations rather than one-time sales.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eBranded products support customer preference and clinical familiarity\u003c\/li\u003e\n  \u003cli\u003ePrivate-brand products support margin control and price competitiveness\u003c\/li\u003e\n  \u003cli\u003eConsumables support repeat ordering behavior\u003c\/li\u003e\n  \u003cli\u003eEquipment supports larger-ticket sales and replacement cycles\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eIn medical distribution, the product set broadens the addressable market beyond dental offices. That matters because it reduces dependence on a single end market and gives Henry Schein more ways to serve ambulatory care and related clinical buyers.\u003c\/p\u003e\n\n\u003cp\u003eSpecialty dental products such as implants and endodontics are strategically important because they sit closer to clinical treatment decisions. These products usually require more technical selling support than basic consumables, so they can deepen customer dependence and improve product mix quality.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eDental implants are tied to restorative and surgical procedures\u003c\/li\u003e\n  \u003cli\u003eEndodontic products support root canal treatment workflows\u003c\/li\u003e\n  \u003cli\u003eSpecialty categories often need training, consultation, and product support\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eHenry Schein One software and Dentrix Ascend add a digital layer to the product portfolio. Dentrix Ascend is a cloud-based practice management platform, so the product is not just software licensing. It is also workflow support for scheduling, charting, billing, and office administration. That makes the product mix more recurring and more embedded in the customer’s daily process.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eSoftware product\u003c\/th\u003e\n    \u003cth\u003eProduct type\u003c\/th\u003e\n    \u003cth\u003eCustomer value\u003c\/th\u003e\n    \u003cth\u003eBusiness impact\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHenry Schein One software\u003c\/td\u003e\n    \u003ctd\u003ePractice management and related software\u003c\/td\u003e\n    \u003ctd\u003eSupports office workflow and patient administration\u003c\/td\u003e\n    \u003ctd\u003eCan increase stickiness and recurring revenue\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDentrix Ascend\u003c\/td\u003e\n    \u003ctd\u003eCloud-based practice management software\u003c\/td\u003e\n    \u003ctd\u003eSupports scheduling, billing, and record management\u003c\/td\u003e\n    \u003ctd\u003eStrengthens software attachment to product sales\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eAcentus homecare CGM supplies expand the product mix into chronic care and patient self-management. CGM means continuous glucose monitoring. In practical terms, that means recurring supply delivery tied to diabetes care. This product category matters because it can create repeat demand and gives Henry Schein exposure to home-based medical supply needs.\u003c\/p\u003e\n\n\u003cp\u003eThe product mix is also shaped by how Henry Schein bundles physical goods with services. The company does not rely only on unit sales. It combines products with ordering, logistics, software, and support, which increases the usefulness of the offer for customers who want one supplier across multiple needs.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003ePhysical goods: consumables, equipment, specialty products, and homecare supplies\u003c\/li\u003e\n  \u003cli\u003eDigital products: practice management software and cloud-based tools\u003c\/li\u003e\n  \u003cli\u003eService-linked products: delivery support, training, and workflow integration\u003c\/li\u003e\n  \u003cli\u003ePrivate-brand items: product alternatives that can support price and margin strategy\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe product structure also helps Henry Schein match different customer buying patterns. Small practices may focus on consumables and software. Larger clinics may buy equipment, implants, and specialty supplies. Medical customers may prioritize recurring supply replenishment. This breadth matters because it lowers reliance on one product line and one type of buyer.\u003c\/p\u003e\n\n\u003cp\u003eFor academic analysis, Henry Schein’s product mix can be studied as a hybrid model: distribution-led, specialty-supported, and software-enabled. That combination is important because it shows how a company can build value across both tangible products and recurring digital and homecare categories.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHenry Schein, Inc. - Marketing Mix: Place\u003c\/h2\u003e\n\n\u003cp\u003eHenry Schein, Inc. operates in \u003cstrong\u003e34 countries and territories\u003c\/strong\u003e and serves \u003cstrong\u003e1M+\u003c\/strong\u003e global customers through a centralized automated distribution network built for daily replenishment and broad product availability.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003ePlace factor\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eReal-life number\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eWhy it matters\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCountries and territories served\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e34\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSupports geographic reach and access across multiple healthcare markets.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eGlobal customer base\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e1M+\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eShows scale in distribution coverage and repeat-order potential.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCartons shipped daily\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eAbout 30,000\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eIndicates high-volume fulfillment and logistics intensity.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSupplier partners\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eRoughly 1,800\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSupports assortment breadth and supply availability.\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe place strategy depends on centralized distribution rather than store-based selling. That matters because dental, medical, and animal health buyers usually need reliable replenishment, not one-time purchases. A network that can process \u003cstrong\u003eabout 30,000 cartons a day\u003c\/strong\u003e supports frequent shipment cycles and helps reduce stockouts for consumable products.\u003c\/p\u003e\n\n\u003cp\u003eServing \u003cstrong\u003e34 countries and territories\u003c\/strong\u003e means the distribution model has to handle cross-border logistics, local customer service, inventory placement, and product availability across multiple regulatory environments. For academic analysis, this shows how place is not just about where products are sold, but also about how supply is organized to meet demand at scale.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003e34\u003c\/strong\u003e countries and territories create a wide delivery footprint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1M+\u003c\/strong\u003e customers increase the importance of routing, order processing, and fill-rate performance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAbout 30,000\u003c\/strong\u003e cartons shipped daily point to a high-throughput fulfillment model.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRoughly 1,800\u003c\/strong\u003e supplier partners support product depth and sourcing flexibility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe supplier base of \u003cstrong\u003eroughly 1,800\u003c\/strong\u003e partners helps Henry Schein, Inc. maintain a broad catalog and reduce dependence on a small number of sources. In distribution terms, this improves assortment coverage, but it also increases the need for supplier coordination, inventory planning, and order accuracy.\u003c\/p\u003e\n\n\u003cp\u003eIn a healthcare distribution business, place also affects service quality. If a clinic or practice cannot get a needed item on time, the customer may switch suppliers. That makes distribution speed, inventory availability, and order reliability part of the value proposition, not just back-office logistics.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003ePlace dimension\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eOperational meaning\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eBusiness impact\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCentralized automated distribution network\u003c\/td\u003e\n    \u003ctd\u003eOrders are processed through coordinated logistics systems.\u003c\/td\u003e\n    \u003ctd\u003eImproves efficiency, consistency, and shipment speed.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eGlobal reach\u003c\/td\u003e\n    \u003ctd\u003eProducts move across \u003cstrong\u003e34\u003c\/strong\u003e countries and territories.\u003c\/td\u003e\n    \u003ctd\u003eExpands market access and supports revenue diversification by geography.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHigh shipment volume\u003c\/td\u003e\n    \u003ctd\u003eAbout \u003cstrong\u003e30,000\u003c\/strong\u003e cartons shipped daily.\u003c\/td\u003e\n    \u003ctd\u003eShows scale and the need for disciplined inventory control.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eLarge supplier network\u003c\/td\u003e\n    \u003ctd\u003eRoughly \u003cstrong\u003e1,800\u003c\/strong\u003e supplier partners.\u003c\/td\u003e\n    \u003ctd\u003eSupports product availability and purchasing flexibility.\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003ePlace in this business model is built around accessibility, speed, and breadth of supply. The numbers show a company that depends on logistics execution to keep products available where and when customers need them.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHenry Schein, Inc. - Marketing Mix: Promotion\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHenry Schein’s promotion mix is B2B-heavy and fact-driven\u003c\/strong\u003e: it leans on investor communications, product and platform announcements, third-party recognition, and professional education channels rather than mass consumer advertising.\u003c\/p\u003e\n\n\u003cp\u003eThe company reported \u003cstrong\u003e$12.3 billion\u003c\/strong\u003e in net sales for 2023 and operated with approximately \u003cstrong\u003e25,000\u003c\/strong\u003e Team Schein members, which gives its promotion program a global sales and communication footprint across dental, medical, and animal health customers.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003ePromotion channel\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eTypical purpose\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eReal-life numeric anchor\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eWhy it matters\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eQuarterly earnings and guidance releases\u003c\/td\u003e\n    \u003ctd\u003eInvestor communication and expectation management\u003c\/td\u003e\n    \u003ctd\u003e4 quarters per year\u003c\/td\u003e\n    \u003ctd\u003eShapes valuation, confidence, and market narrative\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eStrategic plan messaging\u003c\/td\u003e\n    \u003ctd\u003eExplains multi-year operating priorities\u003c\/td\u003e\n    \u003ctd\u003e2025-2027 BOLD+1 plan\u003c\/td\u003e\n    \u003ctd\u003eSignals where capital, product, and sales effort are directed\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHenry Schein One publication content\u003c\/td\u003e\n    \u003ctd\u003ePractice management education and category leadership\u003c\/td\u003e\n    \u003ctd\u003eCatalyst Index\u003c\/td\u003e\n    \u003ctd\u003eCreates demand through data, benchmarking, and workflow evidence\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eProduct announcements\u003c\/td\u003e\n    \u003ctd\u003eShows platform features and innovation\u003c\/td\u003e\n    \u003ctd\u003eAI-platform messaging for Dentrix Ascend\u003c\/td\u003e\n    \u003ctd\u003eSupports adoption of cloud and software solutions\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eEthics recognition\u003c\/td\u003e\n    \u003ctd\u003eReputation and trust building\u003c\/td\u003e\n    \u003ctd\u003e13th consecutive year for Ethisphere recognition in 2024\u003c\/td\u003e\n    \u003ctd\u003eReinforces credibility in regulated healthcare markets\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003e2025-2027 BOLD+1 plan messaging\u003c\/strong\u003e gives Henry Schein a structured promotion theme for customers, investors, and employees. The plan name itself is a message: it frames the company as focused on execution over a \u003cstrong\u003e3-year\u003c\/strong\u003e period rather than short-term campaigns. For academic analysis, this matters because multi-year messaging usually supports brand consistency, internal alignment, and repeated sales talking points across product lines.\u003c\/p\u003e\n\n\u003cp\u003eThe promotion value is not in the slogan alone. It is in repetition across quarterly results, product launches, and sales materials. That kind of message architecture helps a diversified healthcare distributor and software company keep one storyline across dental distribution, software, and value-added services.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTime horizon:\u003c\/strong\u003e 2025-2027\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMessaging role:\u003c\/strong\u003e Strategic alignment across business units\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePromotion impact:\u003c\/strong\u003e Repetition improves recall in B2B buying cycles\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAcademic use:\u003c\/strong\u003e Useful for analyzing integrated marketing communication\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eQuarterly earnings and guidance releases\u003c\/strong\u003e are one of Henry Schein’s most visible promotion tools for capital markets. The company reports results \u003cstrong\u003e4 times per year\u003c\/strong\u003e, and each release typically communicates revenue, operating trends, margin performance, cash flow, and forward-looking guidance. In B2B healthcare, this is not just finance reporting; it is also brand promotion because it tells customers, suppliers, and investors how stable the business is.\u003c\/p\u003e\n\n\u003cp\u003eFor academic work, the key point is that earnings releases promote trust through measurable performance. When a company discusses revenue growth, margin pressure, debt, or guidance, it is shaping perception with numbers, not slogans. That matters in healthcare distribution and software because buyers want continuity, service levels, and product support.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReporting cadence:\u003c\/strong\u003e quarterly\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnnual count:\u003c\/strong\u003e 4 earnings updates\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCore metrics usually discussed:\u003c\/strong\u003e revenue, gross margin, operating margin, earnings per share, cash flow, debt\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePromotion effect:\u003c\/strong\u003e supports credibility with institutional investors and business customers\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eHenry Schein One Catalyst Index publication\u003c\/strong\u003e functions as content-based promotion. A benchmark or index publication is useful because it creates an evidence-led reason for a practice to engage with the company’s software and workflow ecosystem. In plain English, the company is not only selling a product; it is publishing data that encourages practices to compare themselves with peers.\u003c\/p\u003e\n\n\u003cp\u003eThis is a strong promotion tool in dental software because benchmarking can influence purchasing behavior. If a practice sees measurable gaps in scheduling, collections, or clinical workflow performance, it has a reason to consider software that claims to improve those areas. The promotional value comes from data-backed relevance rather than direct advertising spend.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePromotion type:\u003c\/strong\u003e content marketing and thought leadership\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAudience:\u003c\/strong\u003e dental practice owners, managers, and operators\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBusiness effect:\u003c\/strong\u003e supports lead generation and software adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eDentrix Ascend AI-platform announcements\u003c\/strong\u003e are a product-promotion channel aimed at dental practices that want cloud-based workflow tools. AI messaging tends to work well in software promotion because it highlights automation, speed, and decision support. For Henry Schein, the promotional goal is to connect platform features with practice efficiency and modern workflow expectations.\u003c\/p\u003e\n\n\u003cp\u003eThe company’s use of AI in promotion matters because it helps frame software as part of daily operations, not as a separate technology purchase. That is important in healthcare software sales, where adoption depends on training, reliability, and integration with existing practice processes.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProduct category:\u003c\/strong\u003e cloud-based dental practice management software\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePromotion theme:\u003c\/strong\u003e AI-enabled workflow support\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuyer segment:\u003c\/strong\u003e dental practices and multi-location groups\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eEthisphere ethical-company recognition\u003c\/strong\u003e is a reputation-based promotion tool. Henry Schein was recognized in 2024 for the \u003cstrong\u003e13th consecutive year\u003c\/strong\u003e, which signals consistency rather than one-time performance. In healthcare-related industries, ethical recognition matters because customers, suppliers, and regulators pay close attention to trust, compliance, and conduct.\u003c\/p\u003e\n\n\u003cp\u003eThis type of recognition does not directly sell products, but it supports the company’s image in a market where trust is part of the buying decision. It is especially relevant for distribution and software contracts, where customers are often making long-term choices and want a partner with a stable compliance profile.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRecognition count:\u003c\/strong\u003e 13 consecutive years in 2024\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePromotion value:\u003c\/strong\u003e reputation reinforcement\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStrategic impact:\u003c\/strong\u003e supports customer trust in regulated healthcare markets\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003ePromotion activity\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003ePrimary audience\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eFrequency or timing\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003eNumeric or factual anchor\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eBOLD+1 plan messaging\u003c\/td\u003e\n    \u003ctd\u003eInvestors, employees, customers\u003c\/td\u003e\n    \u003ctd\u003e2025-2027\u003c\/td\u003e\n    \u003ctd\u003e3-year plan\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eEarnings releases\u003c\/td\u003e\n    \u003ctd\u003eInvestors and analysts\u003c\/td\u003e\n    \u003ctd\u003eQuarterly\u003c\/td\u003e\n    \u003ctd\u003e4 releases per year\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCatalyst Index\u003c\/td\u003e\n    \u003ctd\u003eDental practice decision-makers\u003c\/td\u003e\n    \u003ctd\u003ePublication-based\u003c\/td\u003e\n    \u003ctd\u003eBenchmarking content\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDentrix Ascend AI messaging\u003c\/td\u003e\n    \u003ctd\u003eDental software buyers\u003c\/td\u003e\n    \u003ctd\u003eProduct-announcement based\u003c\/td\u003e\n    \u003ctd\u003eAI-platform positioning\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eEthisphere recognition\u003c\/td\u003e\n    \u003ctd\u003eCustomers, suppliers, investors\u003c\/td\u003e\n    \u003ctd\u003eAnnual\u003c\/td\u003e\n    \u003ctd\u003e13th consecutive year in 2024\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003ePromotional strategy in this company is built around repeated proof points\u003c\/strong\u003e: planned growth messaging, quarterly financial disclosure, software content, product innovation, and ethics recognition. That combination is important because it reaches different decision-makers with different evidence: numbers for investors, workflow content for users, and trust signals for customers.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHenry Schein, Inc. - Marketing Mix: Price\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e$78.05\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e$61.95\u003c\/strong\u003e to \u003cstrong\u003e$89.29\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e0.00%\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003ePrice metric\u003c\/td\u003e\n    \u003ctd\u003eAmount\u003c\/td\u003e\n    \u003ctd\u003eCalculated difference\u003c\/td\u003e\n    \u003ctd\u003eCalculated percentage\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eStock price\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$78.05\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$16.10 above the 52-week low\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e25.99%\u003c\/strong\u003e above the 52-week low\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e52-week low\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$61.95\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$11.24 below the stock price\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e12.59%\u003c\/strong\u003e below the 52-week high\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e52-week high\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$89.29\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$11.24 above the stock price\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e14.40%\u003c\/strong\u003e above the stock price\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e52-week range width\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$27.34\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$27.34\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e44.14%\u003c\/strong\u003e of the 52-week low\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDividend yield\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e0.00%\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$0.00 dividend yield\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e0.00%\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e2025 share repurchases\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e$70.47\u003c\/strong\u003e average\u003c\/td\u003e\n    \u003ctd\u003e$7.58 below the stock price\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e9.71%\u003c\/strong\u003e below the stock price\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eQ1 2026 share repurchases\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e$77.64\u003c\/strong\u003e average\u003c\/td\u003e\n    \u003ctd\u003e$0.41 below the stock price\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e0.53%\u003c\/strong\u003e below the stock price\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eChange in average repurchase price\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$7.17\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e$7.17 higher in Q1 2026\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e10.17%\u003c\/strong\u003e increase from 2025 to Q1 2026\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003e$78.05\u003c\/strong\u003e places Henry Schein, Inc. between its \u003cstrong\u003e$61.95\u003c\/strong\u003e 52-week low and \u003cstrong\u003e$89.29\u003c\/strong\u003e 52-week high, with a spread of \u003cstrong\u003e$27.34\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe stock traded \u003cstrong\u003e$16.10\u003c\/strong\u003e above the low and \u003cstrong\u003e$11.24\u003c\/strong\u003e below the high, which shows a midpoint position inside the annual range.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e0.00%\u003c\/strong\u003e dividend yield means no cash dividend is reflected in this measure.\u003c\/p\u003e\n\u003cp\u003eShare repurchases averaged \u003cstrong\u003e$70.47\u003c\/strong\u003e in 2025 and \u003cstrong\u003e$77.64\u003c\/strong\u003e in Q1 2026.\u003c\/p\u003e\n\u003cp\u003eThe Q1 2026 repurchase average was \u003cstrong\u003e$7.17\u003c\/strong\u003e higher than the 2025 average.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n  \u003cli\u003e\n\u003cstrong\u003e$78.05\u003c\/strong\u003e stock price\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e$61.95\u003c\/strong\u003e 52-week low\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e$89.29\u003c\/strong\u003e 52-week high\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e0.00%\u003c\/strong\u003e dividend yield\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e$70.47\u003c\/strong\u003e average share repurchase price in 2025\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e$77.64\u003c\/strong\u003e average share repurchase price in Q1 2026\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":44602222379157,"sku":"hsic-marketing-mix","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/hsic-marketing-mix.png?v=1740181272","url":"https:\/\/dcf-model.com\/products\/hsic-marketing-mix","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}